MDxHealth Launches ConfirmMDx™ for Prostate Cancer – Yahoo Finance

MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, today announced the launch of ConfirmMDx™ for Prostate Cancer, a novel test that helps …

Posted in Uncategorized